Home/Intrommune Therapeutics/William E. Berger, MD, MBA

WE

William E. Berger, MD, MBA

Head of Medical Affairs

Intrommune Therapeutics

Therapeutic Areas

Allergy & Immunology Food Allergy

Intrommune Therapeutics Pipeline

Drug	Indication	Phase
INT301 (implied)	Peanut Allergy	Pre-clinical
OMIT Platform	Other Food Allergies (e.g., milk, egg, tree nuts)	Research/Pre-clinical

Leadership Team at Intrommune Therapeutics

Michael Nelson, JD

CEO & Board Member

Strategic Director, Medical Affairs & Clinical Development

View full Intrommune Therapeutics profile